 |
Section sizes
|
Section size for User:HAL333/Parkinson's (54 sections)
| Section name |
Byte
count |
Section
total
|
| (Top) |
5,402 |
5,402
|
| Classification |
2,860 |
2,860
|
| Signs and symptoms |
74 |
22,334
|
| Motor |
6,987 |
6,987
|
| Cognitive |
2,992 |
2,992
|
| Psychosis |
2,124 |
2,124
|
| Neuropsychiatric |
5,697 |
5,697
|
| Gastrointestinal |
2,202 |
2,202
|
| Other |
1,513 |
1,513
|
| Misc |
745 |
745
|
| Causes and risk factors |
853 |
15,843
|
| Genetic |
7,754 |
7,754
|
| Non-genetic |
18 |
7,236
|
| Chemical exposure |
1,544 |
1,544
|
| Head injury |
813 |
813
|
| Medications |
4,126 |
4,126
|
| Infection |
735 |
735
|
| Pathophysiology |
5,031 |
16,194
|
| Brain cell death |
4,532 |
4,532
|
| Neuroimmune connection |
6,631 |
6,631
|
| Diagnosis |
4,648 |
12,942
|
| Imaging |
4,682 |
4,682
|
| Differential diagnosis |
3,612 |
3,612
|
| Prevention |
2,441 |
2,441
|
| Management |
6,383 |
38,507
|
| Medications |
104 |
16,907
|
| Levodopa |
4,673 |
4,673
|
| COMT inhibitors |
4,109 |
4,109
|
| Dopamine agonists |
3,561 |
3,561
|
| MAO-B inhibitors |
1,908 |
1,908
|
| Other drugs |
2,552 |
2,552
|
| Surgery |
3,809 |
3,809
|
| Rehabilitation |
6,696 |
6,696
|
| Palliative care |
4,712 |
4,712
|
| Prognosis |
4,503 |
4,503
|
| Epidemiology |
3,794 |
3,794
|
| History |
6,121 |
6,121
|
| Society and culture |
25 |
8,457
|
| Cost |
1,847 |
1,847
|
| Advocacy |
2,829 |
2,829
|
| Notable cases |
3,756 |
3,756
|
| Research |
2,386 |
9,194
|
| Gene therapy |
2,350 |
2,350
|
| Neuroprotective treatments |
1,629 |
1,629
|
| Cell-based therapies |
1,745 |
1,745
|
| Pharmaceutical |
1,084 |
1,084
|
| Notes and references |
26 |
6,585
|
| Notes |
37 |
37
|
| Citations |
17 |
17
|
| Works cited |
18 |
4,981
|
| Books |
290 |
290
|
| Journal articles |
4,673 |
4,673
|
| News pieces and websites |
1,524 |
1,524
|
| External links |
886 |
886
|
| Total |
156,063 |
156,063
|
| |
